Travere Therapeutics (TVTX) EBITDA (2010 - 2026)
Travere Therapeutics (TVTX) EBITDA from Aug 31, 2010 to Mar 31, 2026. The TTM Travere Therapeutics (TVTX) EBITDA is $16M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual EBITDA
Quarterly EBITDA
Annual EBITDA change of Travere Therapeutics (TVTX)
| Year | EBITDA | Change |
|---|---|---|
| 2026 | -$12M | +462.50% |
| 2025 | -$2.08M | -99.26% |
| 2024 | -$280M | -19.83% |
| 2023 | -$350M | +16.89% |
| 2022 | -$299M | +60.22% |
| 2021 | -$187M | +23.16% |
| 2020 | -$152M | +29.61% |
| 2019 | -$117M | +90.57% |
| 2018 | -$61M | +70.52% |
| 2017 | -$36M | -14.47% |
| 2016 | -$42M | +12.63% |
| 2015 | -$37M | -49.79% |
| 2014 | -$74M | +202.97% |
| 2013 | -$25M | -18.49% |
| 2012 | -$30M | +150550.00% |
| 2011 | -$20K | +100.00% |
| 2010 | -$10K | N/A |